Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

Clinical trial NCT01149629 · COMPLETED

Trial details

NCT number: NCT01149629
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension

Start date: 2010-07-01
Primary completion: 2010-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.